Patent · US Active

Optical system for treating chronobiological disorders and/or myopia

US11774784B2 · kind B2 · utility

1Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2021
Grant dateOct 3, 2023
Priority date
Expiry dateOct 10, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG02C2202/24
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An optical system having a spectral transmission profile having an average transmittance Ta between 380 nm and 780 nm and an average red light transmittance Tr between a first limit L1 and a second limit L2, with Tr<2*Ta/3 and L1=600 nm and L2=780 nm, and the optical system being configured to allow selectively retinal exposure of an eye to at least one selected range of wavelengths of light in the visible spectrum of 460 nm to 530 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.